FDA approves bellafill for treatment of pitted acne scars

FDA approves bellafill for treatment of pitted acne scars

(HealthDay)—The U.S. Food and Drug Administration has approved a new treatment for acne scarring.

Bellafill is an injected gel that adds volume to the skin to lift and smooth out pitted acne scars to the level of the surrounding skin, the agency said. In the study that led to FDA approval, 64 percent of 87 patients treated Bellafill said their skin had improved six months after treatment, compared with 33 percent of 46 patients treated with a placebo.

Also at six months, 84 percent of those treated with Bellafill said they were "very satisfied," "satisfied," or "somewhat satisfied," compared with 52 percent of those treated with a placebo. And doctors, at six months, who didn't know which treatment patients had received judged 84 percent of Bellafill patients "improved" or "much improved," compared to 54 percent of placebo patients.

Bellafill, made by San Diego-based Suneva Medical, costs about $1,000 per injection. The cost, like most , is not covered by insurance, according to Jeffrey Salomon, M.D., an assistant clinical professor of at the Yale University School of Medicine in New Haven, Conn.

Explore further

Laser for tattoo removal appears to improve facial acne scarring

More information: More Information

Copyright © 2015 HealthDay. All rights reserved.

Citation: FDA approves bellafill for treatment of pitted acne scars (2015, January 8) retrieved 5 July 2022 from https://medicalxpress.com/news/2015-01-fda-bellafill-treatment-pitted-acne.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors